Press Releases Biomm S.A.

Equities

BIOM3

BRBIOMACNOR2

Delayed Sao Paulo Other stock markets 14:55:02 17/05/2024 BST			5-day change	1st Jan Change
16.05 ^BRL	-1.89%		-10.83%	+177.68%

04-18	Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil	MT
04-17	Biocon Limited Signs an Exclusive Licensing and Supply Agreement with Biomm S.A	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biomm S A : Webcast Presentation 3Q23	11-14	PU
Biomm S A : Apresentação de resultados 2T23	09/08/23	PU
Biomm S A : Presentation of 1Q22 Results	15/05/22	PU
Biomm S A : Comunicado ao Mercado	03/03/22	PU
CytoDyn : Receives Clearance from Brazil's FDA (ANVISA) to Commence a Pivotal Phase 3 Trial in Critically Ill COVID-19 Patients with IV Administration of Four Doses (700mg/week)	23/09/21	AQ
CytoDyn : Receives Clearance from Brazil's ANVISA to Commence Phase 3 Trial for Severe COVID-19 Patients	04/08/21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer